Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy? (Q61512804)
Jump to navigation
Jump to search
scientific article published on 16 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy? |
scientific article published on 16 November 2006 |
Statements
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? (English)
Vicki Thallas-Bonke
Josefa Pete
Maryann Arnstein
Melinda T Coughlan
David M Long
David C K Tong
Suzanne R Thorpe
Mark E Cooper
16 November 2006